Abstract:High levels of hepatitis B virus (HBV) surface antigen (HBsAg) in the blood of chronic HBV carriers are considered to drive the exhaustion of antigen-specific T and B lymphocytes and thus responsible for the persistence of infection. Accordingly, therapeutic elimination of HBsAg may facilitate the activation of adaptive antiviral immune responses against HBV and achieve a functional cure of chronic hepatitis B. We discovered recently that an amphipathic alpha helix spanning W156 to R169 of HBV small envelope (S) protein plays an essential role in the morphogenesis of subviral particles (SVPs) and metabolism of S protein. We thus hypothesized that pharmacological disruption of SVP morphogenesis may induce intracellular degradation of S protein and reduce HBsAg secretion. To identify inhibitors of SVP biogenesis, we screened 4417 bioactive compounds with a HepG2-derived cell line expressing HBV S protein and efficiently secreting small spherical SVPs. The screen identified 24 compounds that reduced intracellular SVPs and secreted HBsAg in a concentration-dependent manner. However, 18 of those compounds inhibited the secretion of HBsAg and HBeAg in HBV replicon transfected HepG2 cells at similar efficiency, suggesting each of those compounds may disrupt a common cellular function required for the synthesis and/or secretion of these viral proteins. Interestingly, lycorine more efficiently inhibited the secretion of HBsAg in HepG2 cells transfected with HBV replicons, HepG2.2.15 cells and HBV infected - HepG2 cells expressing sodium taurocholate cotransporting polypeptide (NTCP). The structure activity relationship and antiviral mechanism of lycorine against HBV have been determined.

In Vitro Antiviral Activity of Three Enantiomeric Sesquiterpene Lactones from Senecio Species Against Hepatitis B Virus.

Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds

Synthesis and Anti-Hepatitis B Virus Evaluation of Novel Ethyl 6-Hydroxyquinoline-3-carboxylates in Vitro

Structure-Based Molecular Networking for the Discovery of Anti-HBV Compounds from Saussurea lappa (Decne.) C.B Clarke

Activity of Compounds from Chinese Herbal Medicine Rhodiola Kirilowii (regel) Maxim Against Hcvns3 Serine Protease

Synthesis and Evaluation of 3-Phenylisoxazoline Derivatives As Non-Nucleoside Hepatitis B Virus Inhibitors

Synthesis and Biological Evaluation of Phenylpropanoid Derivatives

Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease

Evaluation of Antiviral Activity of Compounds Isolated from Ranunculus Sieboldii and Ranunculus Sceleratus

Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in Vitro

Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents

Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.

In Vitro Study on Anti-Hepatitis C Virus Activity of Spatholobus suberectus Dunn

Hepatitis B virus inhibiting constituents from Herpetospermum caudigerum.

Design, Synthesis, And Bioactive Screen In Vitro Of Cyclohexyl (E)-4-(Hydroxyimino)-4-Phenylbutanoates And Their Ethers For Anti-Hepatitis B Virus Agents

Design, Synthesis, Molecular Docking Studies and Anti-Hbv Activity of Phenylpropanoid Derivatives

In Vitro Antiviral Activity of Lutein Against Hepatitis B Virus

Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.

Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library

In Vitro Anti-Hbv Activities of Phyllocoumarin and ( - )-Epicatechin from Schisandra Land Folia

Antiviral Activity of the Sesquiterpene Lactones from Centipeda minima against Influenza a Virus in vitro